(45), approximately 25% of LEL-HCC cases harbour a focal amplification at 11q13.3, a locus that contains CCND1, FGF19, and FGF4. This gene alteration is minimally detected in conventional HCC. The gene discussed is FGF4; the disease is hepatocellular carcinoma.